Page last updated: 2024-08-23

simvastatin and Thromboembolism

simvastatin has been researched along with Thromboembolism in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hauta-Aho, M; Helin-Salmivaara, A; Huupponen, R; Kastarinen, H; Korhonen, MJ; Rikala, M; Tiittanen, P	1

Other Studies

2 other study(ies) available for simvastatin and Thromboembolism

Article	Year
Statins do not Increase the Rate of Bleeding Among Warfarin Users. Basic & clinical pharmacology & toxicology, 2018, Volume: 123, Issue:2 Topics: Aged; Anticoagulants; Drug Interactions; Female; Finland; Gastrointestinal Hemorrhage; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intracranial Hemorrhages; Male; Middle Aged; Retrospective Studies; Risk Factors; Simvastatin; Thromboembolism; Treatment Outcome; Warfarin	2018
[Reconsideration of the therapy of coronary heart disease is needed. Symposium: "Prevention and Treatment of Coronary Disease", part of the 103rd Congress of the German Society of Internal Medicine. Wiesbaden, 6 April 1997]. Deutsche medizinische Wochenschrift (1946), 1997, Volume: 122, Issue:42 Suppl U Topics: Anticholesteremic Agents; Coronary Disease; Diabetes Complications; Germany; Humans; Hypercholesterolemia; Lipoproteins, LDL; Risk Factors; Simvastatin; Thromboembolism	1997

Article

Year

Statins do not Increase the Rate of Bleeding Among Warfarin Users.

Basic & clinical pharmacology & toxicology, 2018, Volume: 123, Issue:2

Topics: Aged; Anticoagulants; Drug Interactions; Female; Finland; Gastrointestinal Hemorrhage; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intracranial Hemorrhages; Male; Middle Aged; Retrospective Studies; Risk Factors; Simvastatin; Thromboembolism; Treatment Outcome; Warfarin

2018

[Reconsideration of the therapy of coronary heart disease is needed. Symposium: "Prevention and Treatment of Coronary Disease", part of the 103rd Congress of the German Society of Internal Medicine. Wiesbaden, 6 April 1997].

Deutsche medizinische Wochenschrift (1946), 1997, Volume: 122, Issue:42 Suppl U

Topics: Anticholesteremic Agents; Coronary Disease; Diabetes Complications; Germany; Humans; Hypercholesterolemia; Lipoproteins, LDL; Risk Factors; Simvastatin; Thromboembolism

1997